Understanding Wet Age-Related Macular Degeneration (AMD)

---

Wet AMD, also known as neovascular AMD, is a chronic, progressive eye disease and one of the leading causes of vision loss in older adults. It affects the macula—the central part of the retina responsible for sharp, detailed vision. This condition can severely impact daily activities such as reading, driving, and recognizing faces.

Wet AMD occurs when abnormal blood vessels grow beneath the retina and leak fluid or blood. This process, called choroidal neovascularization, leads to swelling and scarring of retinal tissue. Unlike dry AMD, which progresses slowly, wet AMD can cause rapid and significant vision loss if left untreated.

• Age: Most common in individuals over 60 years old.
• Genetics: Family history increases susceptibility.
• Lifestyle: Smoking, poor diet, and cardiovascular disease are known contributors.
• Other Factors: High blood pressure and obesity may also play a role.

 Blurred or distorted central vision.

• Straight lines appearing wavy.
• Dark or empty areas in the center of vision.
• Rapid worsening of visual clarity.

Wet AMD can make everyday tasks challenging, leading to loss of independence and emotional distress. Early diagnosis and treatment are essential to preserve vision and maintain quality of life.

The standard of care involves anti-VEGF (vascular endothelial growth factor) therapies, which inhibit abnormal blood vessel growth and leakage. These treatments have revolutionized AMD management, significantly reducing the risk of severe vision loss.

At Medvisis, we focus on biosimilars that meet the highest standards of quality and safety. Biosimilars are highly similar to an already approved biologic medicine, with no clinically meaningful differences in efficacy, safety, or immunogenicity. They represent a key solution for sustainable healthcare by combining proven therapeutic outcomes with cost efficiency.

Medvisis provides innovative solutions for the treatment of wet age-related macular degeneration. For further details, contact us at info@medvisis.com.